Trials / Completed
CompletedNCT05909553
Study to Assess Adverse Events and Compare How Crushed, Ground, and Intact Oral Tablets Venetoclax Moves Through the Body of Healthy Female Adult Volunteers
A Phase 1, Open-Label Study to Evaluate the Effect of Crushing and Grinding on the Bioavailability of Venetoclax Tablet in Healthy Adult Female Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to assess the oral bioavailability of crushed and ground venetoclax commercial tablets relative to the intact venetoclax commercial tablets under fed condition in healthy female participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Venetoclax | Oral; Tablet |
Timeline
- Start date
- 2023-06-15
- Primary completion
- 2023-09-22
- Completion
- 2023-09-22
- First posted
- 2023-06-18
- Last updated
- 2023-12-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05909553. Inclusion in this directory is not an endorsement.